James Hippel Bio Techne Corp (TECH) insider trading activity

TECH Quotes by TradingView

James Hippel is CFO of BIO-TECHNE Corp. Currently has a direct ownership of 129,883 shares of TECH, which is worth approximately $6.89 Million. The most recent transaction as insider was on Aug 09, 2021, when has been sold 10,000 shares (Common Stock) at a price of $480.97 per share, resulting in proceeds of $4,809,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130K
21.83% 3M change
29.98% 12M change
Total Value Held $6.89 Million

James Hippel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2021
SELL
Open market or private sale
$4,809,700 $480.97 p/Share
10,000 Reduced 47.95%
10,855 Common Stock
Aug 09 2021
BUY
Exercise of conversion of derivative security
$1,065,900 $106.59 p/Share
10,000 Added 32.41%
20,855 Common Stock
Aug 08 2021
SELL
Payment of exercise price or tax liability
$802,230 $481.82 p/Share
1,665 Reduced 13.3%
10,855 Common Stock
Aug 08 2021
BUY
Exercise of conversion of derivative security
-
3,383 Added 21.27%
12,520 Common Stock
Jul 12 2021
SELL
Open market or private sale
$4,578,000 $457.8 p/Share
10,000 Reduced 52.25%
9,137 Common Stock
Jul 12 2021
BUY
Exercise of conversion of derivative security
$1,065,900 $106.59 p/Share
10,000 Added 34.32%
19,137 Common Stock
Jun 07 2021
SELL
Open market or private sale
$4,198,208 $422.27 p/Share
9,942 Reduced 52.11%
9,137 Common Stock
Jun 07 2021
BUY
Exercise of conversion of derivative security
$1,059,718 $106.59 p/Share
9,942 Added 34.26%
19,079 Common Stock
Feb 12 2021
SELL
Open market or private sale
$4,009,200 $400.92 p/Share
10,000 Reduced 52.25%
9,137 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
$1,065,900 $106.59 p/Share
10,000 Added 34.32%
19,137 Common Stock
Jan 11 2021
SELL
Open market or private sale
$3,321,900 $332.19 p/Share
10,000 Reduced 52.25%
9,137 Common Stock
Jan 11 2021
BUY
Exercise of conversion of derivative security
$1,065,900 $106.59 p/Share
10,000 Added 34.32%
19,137 Common Stock
Nov 11 2020
SELL
Open market or private sale
$2,271,624 $307.35 p/Share
7,391 Reduced 44.72%
9,137 Common Stock
Nov 11 2020
BUY
Exercise of conversion of derivative security
$787,807 $106.59 p/Share
7,391 Added 30.9%
16,528 Common Stock
Nov 09 2020
SELL
Open market or private sale
$1,115,496 $309.86 p/Share
3,600 Reduced 28.26%
9,137 Common Stock
Nov 09 2020
BUY
Exercise of conversion of derivative security
$383,724 $106.59 p/Share
3,600 Added 22.04%
12,737 Common Stock
Nov 05 2020
SELL
Open market or private sale
$2,521,224 $286.21 p/Share
8,809 Reduced 49.09%
9,137 Common Stock
Nov 05 2020
BUY
Exercise of conversion of derivative security
$955,688 $108.49 p/Share
8,809 Added 32.92%
17,946 Common Stock
Nov 04 2020
SELL
Open market or private sale
$1,946,607 $274.17 p/Share
7,100 Reduced 43.73%
9,137 Common Stock
Nov 04 2020
BUY
Exercise of conversion of derivative security
$770,279 $108.49 p/Share
7,100 Added 30.42%
16,237 Common Stock
JH

James Hippel

CFO
Minneapolis, MN

Track Institutional and Insider Activities on TECH

Follow BIO-TECHNE Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TECH shares.

Notify only if

Insider Trading

Get notified when an Bio Techne Corp insider buys or sells TECH shares.

Notify only if

News

Receive news related to BIO-TECHNE Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TECH